Mark P S Dunphy

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Association of vascular 18F-FDG uptake with vascular calcification
    Mark P S Dunphy
    Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 46:1278-84. 2005
  2. ncbi request reprint Molecular imaging of atherosclerosis
    Mark P S Dunphy
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room S 223A, New York, NY 10021, USA
    Curr Cardiol Rep 10:121-7. 2008
  3. pmc In vivo microcartography and subcellular imaging of tumor angiogenesis: a novel platform for translational angiogenesis research
    Mark P S Dunphy
    Sloan Kettering Institute for Cancer Research, 418 East 68th Street, New York, NY 10065, USA
    Microvasc Res 78:51-6. 2009
  4. pmc Dosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging
    Mark P S Dunphy
    Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room H 214B, Box 77, New York, NY 10065, USA
    Mol Imaging Biol 14:25-31. 2012
  5. pmc Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm
    Jun ichi Nitadori
    Division of Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:4282-8. 2013
  6. pmc FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma
    Kyuichi Kadota
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:3598-605. 2012
  7. ncbi request reprint Radionuclide techniques for identifying vulnerable plaque
    Mark P S Dunphy
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Nucl Med 48:1753-5. 2007
  8. pmc Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET
    Mark P S Dunphy
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Nucl Med 50:106S-21S. 2009
  9. pmc The epichaperome is an integrated chaperome network that facilitates tumour survival
    Anna Rodina
    Program in Chemical Biology, Sloan Kettering Institute, New York, New York 10065, USA
    Nature 538:397-401. 2016

Collaborators

  • Steven M Larson
  • HARRY W STRAUSS
  • Nagavarakishore Pillarsetty
  • Jason S Lewis
  • Prasad S Adusumilli
  • Oscar Lin
  • Akihiko Yoshizawa
  • Romel Somwar
  • William D Travis
  • Heiko Schoder
  • Anna Rodina
  • Jun ichi Nitadori
  • Nabil P Rizk
  • Valerie W Rusch
  • Camelia S Sima
  • Kyuichi Kadota
  • Hongliang Zong
  • Monica L Guzman
  • John Koren
  • Sujata Patil
  • Eloisi Caldas-Lopes
  • Shanu Modi
  • Mohammad F Farooq
  • Chao Xu
  • Lorenz Studer
  • Ross Levine
  • Erica DaGama Gomes
  • Hediye Erdjument-Bromage
  • Pat Zanzonico
  • Mary Alpaugh
  • Alexander Bolaender
  • Christina Pressl
  • Clifford Hudis
  • Gail J Roboz
  • John F Gerecitano
  • Ari Melnick
  • Chenghua Yang
  • Tai Wang
  • Hardik J Patel
  • Fumiko Shimizu
  • Robert Trondl
  • Palak Panchal
  • Feixia Chu
  • Brad Beattie
  • Radu I Peter
  • Tony Taldone
  • Sarah Kishinevsky
  • Pengrong Yan
  • Ethel Cesarman
  • Matthew Riolo
  • Leandro Cerchietti
  • Gabriela Chiosis
  • Adriana Corben
  • Adam J Bograd
  • Eduardo A Morales
  • Emily C Zabor
  • Christos Colovos
  • Kei Suzuki

Detail Information

Publications9

  1. ncbi request reprint Association of vascular 18F-FDG uptake with vascular calcification
    Mark P S Dunphy
    Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 46:1278-84. 2005
    ..This investigation examines the geographic relationship of focal vascular (18)F-FDG uptake, as a marker of atherosclerotic inflammation, to arterial calcification detected by contemporaneous CT...
  2. ncbi request reprint Molecular imaging of atherosclerosis
    Mark P S Dunphy
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room S 223A, New York, NY 10021, USA
    Curr Cardiol Rep 10:121-7. 2008
    ..Molecular imaging can provide a "virtual histology" noninvasively about atherosclerotic disease, characterizing vascular lesions with markers of inflammation, angiogenesis, lipid metabolism, and more...
  3. pmc In vivo microcartography and subcellular imaging of tumor angiogenesis: a novel platform for translational angiogenesis research
    Mark P S Dunphy
    Sloan Kettering Institute for Cancer Research, 418 East 68th Street, New York, NY 10065, USA
    Microvasc Res 78:51-6. 2009
    ..To eliminate the variable of tumor heterogeneity from a novel in vivo model of tumor angiogenesis...
  4. pmc Dosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging
    Mark P S Dunphy
    Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room H 214B, Box 77, New York, NY 10065, USA
    Mol Imaging Biol 14:25-31. 2012
    ..F-SKI-249380 is a first-of-its-kind PET tracer for imaging the in vivo pharmacokinetics of dasatinib, an investigational targeted therapy for solid malignancies...
  5. pmc Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm
    Jun ichi Nitadori
    Division of Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:4282-8. 2013
    ..We investigated the prognostic value of preoperative consolidation/tumor (C/T) ratio [on computed tomography (CT) scan] and maximum standardized uptake value (SUVmax) on (18)F-fluorodeoxyglucose-positron emission tomography (PET) scan...
  6. pmc FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma
    Kyuichi Kadota
    Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:3598-605. 2012
    ....
  7. ncbi request reprint Radionuclide techniques for identifying vulnerable plaque
    Mark P S Dunphy
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Nucl Med 48:1753-5. 2007
  8. pmc Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET
    Mark P S Dunphy
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Nucl Med 50:106S-21S. 2009
    ....
  9. pmc The epichaperome is an integrated chaperome network that facilitates tumour survival
    Anna Rodina
    Program in Chemical Biology, Sloan Kettering Institute, New York, New York 10065, USA
    Nature 538:397-401. 2016
    ..The epichaperome, present in over half of all cancers tested, has implications for diagnostics and also provides potential vulnerability as a target for drug intervention...